Cefazolin in chronic hemodialysis patients: a safe, effective alternative to vancomycin.

Fogel, M A

Cefazolin in chronic hemodialysis patients: a safe, effective alternative to vancomycin. [electronic resource] - American journal of kidney diseases : the official journal of the National Kidney Foundation Sep 1998 - 401-9 p. digital

Publication Type: Comparative Study; Journal Article

1523-6838

10.1053/ajkd.1998.v32.pm9740155 doi


Ambulatory Care
Anti-Bacterial Agents--adverse effects
Bacteremia--blood
Cefazolin--adverse effects
Cephalosporins--adverse effects
Drug Therapy, Combination
Enterococcus--drug effects
Gentamicins--adverse effects
Gram-Negative Bacterial Infections--blood
Gram-Positive Bacterial Infections--blood
Humans
Metabolic Clearance Rate--physiology
Methicillin Resistance
Microbial Sensitivity Tests
Renal Dialysis
Staphylococcus--drug effects
Vancomycin--adverse effects
Wound Infection--blood